Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma

specific

The reemergence of primary cutaneous T-cell non-Hodgkin lymphoma after a period of remission.

25

Centers

1

Active Trials

Cancer Funding

Top Centers for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma(25)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
81.6
2
NCI Comprehensive
Active Research Program
60.7
3
NCI Comprehensive
Active Research Program
59.9
4
NCI Comprehensive
Active Research Program
58.3
5
NCI Comprehensive
Active Research Program
57.5
6
NCI Comprehensive
Active Research Program
56.7
7
NCI Comprehensive
Active Research Program
55.9
8
NCI Comprehensive
Active Research Program
55.1
9
NCI Comprehensive
Active Research Program
54.3
10
NCI Comprehensive
Active Research Program
53.5
11
NCI Comprehensive
Active Research Program
52.7
12
NCI Clinical
Active Research Program
51.9
13
NCI Comprehensive
Active Research Program
51.1
14
Active Research Program
50.3
15
NCI Comprehensive
Active Research Program
49.5
16
NCI Comprehensive
Active Research Program
48.7
17
Active Research Program
47.9
18
Active Research Program
47.1
19
NCI Comprehensive
Active Research Program
46.3
20
NCI Comprehensive
Active Research Program
45.5
21
NCI Comprehensive
Active Research Program
44.7
2242.7
2342.7
2442.7
2542.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →